← Back to Search

Behavioural Intervention

NuvoAir Clinical service for Chronic Obstructive Pulmonary Disease (PROMISE Trial)

N/A

Recruiting

Led By Jeffrey VanWormer, PHD

Research Sponsored by NuvoAir Medical PC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Are age ≥30 years

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

PROMISE Trial Summary

This trial is looking at whether using the NuvoAir clinical service can help reduce the number of severe COPD exacerbations, hospitalizations, emergency room visits, and overall cost of care for people with

Who is the study for?

This trial is for people over 30 years old with COPD, including conditions like emphysema and chronic bronchitis. Participants must have been diagnosed in the last two years and need access to a smartphone or telephone.Check my eligibility

What is being tested?

The study tests if the NuvoAir Clinical Service can reduce severe flare-ups, hospital visits, emergency room trips, and overall costs of care for COPD patients compared to those not using this service over a period of 12 months.See study design

What are the potential side effects?

Since the intervention involves a clinical service rather than medication, traditional side effects are not applicable. However, there may be indirect effects related to changes in disease management.

PROMISE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 30 years old or older.

PROMISE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Moderate & Severe Exacerbations

Secondary outcome measures

Cost of care

Hospital days

Readmissions

PROMISE Trial Design

2Treatment groups

Experimental Treatment

Group I: Standard CareExperimental Treatment0 Interventions

Propensity matched controls with COPD who receive usual care.

Group II: NuvoAir Clinical serviceExperimental Treatment1 Intervention

Patients with COPD receiving usual care plus NuvoAir clinical services.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

NuvoAir Medical PCLead Sponsor

1 Previous Clinical Trials

1,050 Total Patients Enrolled

Jeffrey VanWormer, PHDPrincipal InvestigatorMarshfield Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial currently seeking and enrolling participants?

"According to the current information available on clinicaltrials.gov, this study is actively seeking participants. The initial posting of the trial occurred on July 24th, 2023, and it was last updated on December 13th, 2023."

Answered by AI

What is the upper limit in terms of patient enrollment for this medical study?

"Indeed, the information available on clinicaltrials.gov confirms that this trial is currently seeking eligible participants. The trial was first posted on July 24th, 2023 and last updated on December 13th, 2023. The study aims to enroll a total of 500 patients from a single location."

Answered by AI